Culture medium and method for inducing pluripotent stem cells to differentiate into hematopoietic stem cells
A technology for pluripotent stem cells and hematopoietic stem cells, which is applied in the field of culture medium for inducing pluripotent stem cells to differentiate into hematopoietic stem cells, can solve the problems of low efficiency of hematopoietic stem cells, pollution, restricting the clinical application of umbilical cord blood hematopoietic stem cells, etc. The effect of solving pollution
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] This example provides a medium and a method for differentiating induced pluripotent stem cells (iPS) into hematopoietic stem cells.
[0030] The medium used in this embodiment includes the first-stage medium and the second-stage medium:
[0031] In the medium of the first stage, the final concentration ratio of SCF, BMP4, IL-3, VEGF, and Flt3 is 2:1:1:1:1, and the specific formula is: add a final concentration of 10% ( v / v) fetal bovine serum, thioglycerol (MTG) with a final concentration of 100 μmol / L, and bone cells with a final concentration of 40 ng / mL of stem cell factor (SCF) and a final concentration of 20 ng / mL. Morphogenetic protein 4 (BMP4), interleukin-3 (IL-3) at a final concentration of 20 ng / mL, VEGF at a final concentration of 20 ng / mL, and Flt3 at a final concentration of 20 ng / mL.
[0032] The final concentration ratio of SCF, BMP4, IL-3, VEGF, Flt3, and UM171 in the medium of the second stage is 2:1:1:1:1:5, and the specific formula is: add a final co...
Embodiment 2
[0039] This example is a modification of Example 1, and the only difference is that embryonic stem cells (ES) are selected as the type of pluripotent stem cells.
[0040] For comparison, this embodiment also sets up a comparison group. The difference between the comparison group and this embodiment is only that the culture medium of the following formula is only used to induce differentiation once: a-MEM medium is added with a final concentration of 10% (v / v) fetal bovine serum, thioglycerol (MTG) at a final concentration of 100 μmol / L.
Embodiment 3
[0042] This embodiment is a modification example of Embodiment 1, and the change is only in the component contents of the first-stage culture medium and the second-stage culture medium:
[0043] The final concentration ratio of SCF, BMP4, IL-3, VEGF and Flt3 in the medium of the first stage is 2.25:1:1:1:1, and the specific components are: the final concentration of 10% ( v / v) fetal bovine serum, thioglycerol (MTG) at a final concentration of 100 μmol / L, and bone cells with a final concentration of 45 ng / mL of stem cell factor (SCF) and a final concentration of 20 ng / mL. Morphogenetic protein 4 (BMP4), interleukin-3 (IL-3) with a final concentration of 20 ng / mL, VEGF with a final concentration of 20 ng / mL, and Flt3 with a final concentration of 20 ng / mL;
[0044] The final concentration ratio of SCF, BMP4, IL-3, VEGF and Flt3 in the medium of the second stage is 2.25:1:1:1:1:1:4.5, and the specific formula is: add the final concentration of 10% to the a-MEM medium (v / v) fetal...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


